ERP44 and oral cavity squamous cell carcinoma: Treatment of oral squamous cell carcinoma (OSCC) cell lines, HN-22 and HSC-4, with honokiol caused degradation of ERp44 in a dose- and time-dependent manner without affecting ERp44 mRNA expression.